Natural products: an evolving role in future drug discovery

BB Mishra, VK Tiwari - European journal of medicinal chemistry, 2011 - Elsevier
The therapeutic areas of infectious diseases and oncology have benefited from abundant
scaffold diversity in natural products, able to interact with many specific targets within the cell …

The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections

P Mehrbod, SR Ande, J Alizadeh, S Rahimizadeh… - Virulence, 2019 - Taylor & Francis
Virus infection induces different cellular responses in infected cells. These include cellular
stress responses like autophagy and unfolded protein response (UPR). Both autophagy and …

Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors

JY Park, HJ Yuk, HW Ryu, SH Lim, KS Kim… - Journal of enzyme …, 2017 - Taylor & Francis
The current study was designed to assess the inhibitory activity of Broussonetia papyrifera-
derived polyphenols against 3-chymotrypsin-like and papain-like coronavirus cysteine …

Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

V Boldescu, MAM Behnam, N Vasilakis… - Nature Reviews Drug …, 2017 - nature.com
Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging
Zika virus, are an increasing and probably lasting global risk. This Review summarizes and …

Potential antiviral action of alkaloids

FL Abookleesh, BS Al-Anzi, A Ullah - Molecules, 2022 - mdpi.com
Viral infections and outbreaks have become a major concern and are one of the main
causes of morbidity and mortality worldwide. The development of successful antiviral …

Ten years of dengue drug discovery: progress and prospects

SP Lim, QY Wang, CG Noble, YL Chen, H Dong, B Zou… - Antiviral research, 2013 - Elsevier
To combat neglected diseases, the Novartis Institute of Tropical Diseases (NITD) was
founded in 2002 through private–public funding from Novartis and the Singapore Economic …

[HTML][HTML] Recent advances in antiviral drug development towards dengue virus

B Troost, JM Smit - Current opinion in virology, 2020 - Elsevier
Highlights•Evaluating drug efficacy, specificity and toxicity may help to develop an optimal
treatment regime for in vivo studies.•Measuring time to resolve viremia in vivo may help to …

An adenosine nucleoside inhibitor of dengue virus

Z Yin, YL Chen, W Schul, QY Wang… - Proceedings of the …, 2009 - National Acad Sciences
Dengue virus (DENV), a mosquito-borne flavivirus, is a major public health threat. The virus
poses risk to 2.5 billion people worldwide and causes 50 to 100 million human infections …

In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting

AI Trujillo-Correa, DC Quintero-Gil… - … and alternative medicine, 2019 - Springer
Background For decades, bioprospecting has proven to be useful for the identification of
compounds with pharmacological potential. Considering the great diversity of Colombian …

Alkaloids as potential antivirals. A comprehensive review

S Faisal, SL Badshah, B Kubra, AH Emwas… - Natural Products and …, 2023 - Springer
Alkaloids are a diverse group of natural phytochemicals. These phytochemicals in plants
provide them protection against pests, and herbivorous organisms and also control their …